News & Updates

Treatment with the monoclonal antibody targeting interleukin [IL]-23p19 guselkumab 100 mg, given either every 4 (Q4W) or 8 weeks (Q8W), is well tolerated in patients with psoriatic arthritis (PsA), with no new safety concerns through 1 year, according to pooled results of the DISCOVER-1 and DISCOVER-2 phase III trials.

Abstinence from alcoholic drinks reduces the risk of hepatocellular carcinoma (HCC) in patients with alcohol-related liver cirrhosis, but not in those with a history of decompensated disease, reveals a study.

A diet with increased consumption of fruits, vegetables, breakfast cereals, and dietary fibre, as well as low intake of red and processed meat, appears to reduce the risk of lung cancer, suggests a study.

Parkinson’s disease (PD) significantly impairs activity even when patients are in their natural environment, according to a recent real-world study.

Individuals who make eating before bedtime a habit risk developing hypertension, a study reports.

The combination of carbocisteine, gingko leaf extract, and milrinone yields significant clinical improvement in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD), a recent study has found. In turn, this treatment regimen also leads to better patient quality of life.